鴉片類促效劑藥物市場：依產品、治療應用及地區分類。

Opioids Agonist Drugs Market, By Product, By Therapeutic Application, By Geography

出版日期: 2026年05月21日 | 出版商:

Coherent Market Insights | 英文 153 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，鴉片類促效劑藥物市場規模將達到 269.36 億美元，到 2033 年將達到 359.452 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 4.2%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	269.36億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	4.20%	2033年市場規模預測：	359.452億美元

鴉片類藥物作用於中樞和周邊神經系統中的鴉片受體。這類藥物主要用於緩解疼痛，包括天然鴉片類藥物、半合成鴉片類藥物和合成鴉片類藥物。可待因、氫可酮、氫可酮、羥考酮、海洛因和Fentanyl是全球鴉片類促效劑市場的主要處方藥。鴉片類藥物的給藥途徑包括口服片劑、注射、液體、貼片或錠劑。藥物過量和濫用是全球衛生當局關注的主要問題，尤其是在這些藥物易於取得的已開發地區。根據2016年全球藥物報告，高達1,740萬人受到鴉片類藥物濫用的影響。因此，藥品和衛生當局正在努力控制鎮痛藥的處方，並遏制鴉片類藥物的濫用。美國食品藥物管理局（FDA）將所有鴉片類藥物列為“二級管制藥品”，這意味著它們具有極高的濫用風險。 2016 年，美國疾病管制與預防中心 (CDC) 發布了鴉片類藥物處方指南，將鴉片類藥物的每日劑量限制為 90 毫克氫可酮當量 (MME)。

市場動態

根據美國疼痛協會發布的美國國立衛生研究院 (NIH) 2015 年的估計數據，美國約有 5,000 萬人患有慢性疼痛。鴉片類藥物對癌症疼痛、整形外科疼痛、神經性疼痛、術後疼痛和下背痛非常有效。隨著慢性疼痛盛行率的增加，對鴉片類藥物的需求也必然隨之成長。

北美是全球最大的鴉片類藥物市場，這主要歸功於品牌處方藥和本地產品的易得性，但也無意中助長了藥物濫用。幾乎所有鴉片類藥物衍生物都有本地生產的非品牌產品，與現有的處方鴉片類藥物品牌形成互補。根據美國疾病管制與預防中心（CDC）的數據顯示，2015年美國73%的藥物過量死亡是由鴉片類藥物引起的（2010年這一比例為57%）。此外，大麻作為鴉片類藥物的替代品出現，並在多個地區合法化，這正在抑制鴉片類藥物市場的成長。

市場分類

本報告根據藥物類型、應用和地區對全球鴉片類促效劑市場進行細分。依藥物類型分類，全球鴉片類藥物市場分為可待因、氫可酮、Fentanyl、美沙酮和氫可酮。按應用分類，市場分為疼痛管理和腹瀉咳嗽治療。疼痛管理進一步細分為神經性疼痛、偏頭痛、背痛、骨關節炎疼痛、癌症疼痛和其他疼痛。為了全面了解市場動態，本報告按北美、歐洲、亞太、拉丁美洲、非洲和中東等主要地區對全球鴉片類藥物市場進行分析。對於每個地區，分析均基於該地區主要國家的市場調查結果，以從宏觀層面了解市場。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、區域前景以及主要參與者採取的競爭策略。
本研究根據以下參數對全球鴉片類促效劑藥物市場的主要參與者進行了分析：公司概況、財務業績、產品系列、企業發展區域、分銷策略、主要發展和策略以及未來計劃。
透過利用本報告中的見解，企業負責人和經營團隊將能夠就未來的產品發布、終端用戶升級、市場擴張和行銷策略做出明智的決策。
這份全球鴉片類促效劑藥物市場報告旨在為業內各種相關人員提供參考，包括投資者、鴉片類藥物產品的製造商和經銷商、衛生和監管機構、研究和諮詢公司、新參與企業和金融分析師。
用於分析鴉片類藥物市場的各種策略矩陣為相關人員提供了做出適當策略決策的關鍵資訊。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第7章競爭情勢

熱圖分析
市佔率分析
公司簡介
- Pfizer Inc.
- Purdue Pharma
- Boehringer Ingelheim
- Janssen Pharmaceuticals, Inc.
- Actavis Plc.
- Sanofi
- Sun Pharmaceutical Industries Ltd.
- Mallinckrodt Pharmaceuticals
- Egalet Corporation
- Endo Pharmaceuticals Inc.

第8章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI135

Opioids Agonist Drugs Market is estimated to be valued at USD 26,936.0 Mn in 2026 and is expected to reach USD 35,945.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 4.2% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 26,936.0 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	4.20%	2033 Value Projection:	USD 35,945.2 Mn

Opioid drugs act on the opioid receptors present in the central and peripheral nervous system. The drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic opioids. Codeine, morphine, hydrocodone, oxycodone, heroin, and fentanyl are some of the major prescription drugs in the global opioids agonist drugs market. Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges. Overdose and drug abuse is a major concern for health regulators worldwide, with the situation especially alarming in developed regions with easy access to these drugs. According to the World Drug Report 2016, a staggering 17.4 million people were affected by opioid drug abuse. Drug and health regulators are therefore, taking initiatives to govern pain prescriptions and curb the rate of opioid abuse. The U.S. FDA considers all opioids as schedule 2 drugs-drugs that have high abuse potential. In 2016, the CDC issued guidelines to prescribe opioids, limiting the daily dose of opioids to 90 morphine milligram equivalent (MME).

Market Dynamics

According to the National Institutes of Health (NIH) estimates published in 2015 by the American Pain Society, nearly 50 million people in the U.S. suffered from chronic pain. Use of opioids in cancer pain, orthopedic pain, neuropathic pain, post-operative pain, and lower back pain is very effective. With growing incidence of chronic pain, demand for opioids will also increase consequently.

North America is the largest market for opioids owing to availability of branded prescription and local products, which inadvertently also leads to drug abuse. There are local unbranded products available for every opioid derivative complementing the available prescription opioid brand. The Centers for Disease Control and Prevention (CDC) states that 73% of all drug overdose deaths in the U.S. in 2015 were due to opioids (57% in 2010). Moreover, emergence of cannabis as an alternative to opioids and legalization of the same in various regions is inhibiting the opioids market growth.

Market Taxonomy

This report segments the global opioids agonist drugs on the basis of drug type, application, and geography. On the basis of drug type, the global opioids market is categorized into codeine, morphine, fentanyl, methadone and hydrocodone. On the basis of application, the market is segmented into pain management, diarrhea and cough treatment. Pain Management is further segmented into Neuropathic Pain, Migraine, Back Pain, Osteoarthritis Pain, Cancer Pain, and Others. For comprehensive understanding of market dynamics, the global opioids market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Key features of the study

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global opioids agonist drugs market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
Key companies covered as a part of this study include Purdue Pharma L.P., Janssen Pharmaceuticals, Inc., West - Ward Pharmaceuticals Corporation, Pfizer, Inc., Egalet Corporation, Allergan plc, Sanofi SA, Boehringer Ingelheim, and Sun Pharmaceutical Industries Ltd.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, end user upgrades, market expansion, and marketing tactics
The global opioids agonist drugs market report caters to various stakeholders in this industry, including investors, manufacturers and distributors for opioid products, health and regulatory agencies, research and consulting firms, new entrants, and financial analysts
Various strategy matrices used in analyzing the opioids market would provide stakeholders vital inputs to make strategic decisions accordingly

Market Segmentation

By Product (Revenue, USD Mn, 2021-2033)
- Codeine
- Fentanyl
- Meperidine
- Methadone
- Morphine
- Hydrocodone
By Therapeutic Application (Revenue, USD Mn, 2021-2033)
- Pain Management
- Neuropathic Pain Migraine
- Back Pain
- Osteoarthritis Pain
- Cancer Pain
- Others
- Cough Treatment
- Diarrhea Treatment
By Region (Revenue, USD Mn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Key Players
- Pfizer Inc.
- Purdue Pharma
- Boehringer Ingelheim
- Janssen Pharmaceuticals, Inc.
- Actavis Plc.
- Sanofi
- Sun Pharmaceutical Industries Ltd.
- Mallinckrodt Pharmaceuticals
- Egalet Corporation
- Endo Pharmaceuticals Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Therapeutic Application
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Opioids Agonist Drugs Market, By Product, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Codeine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Fentanyl
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Meperidine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Methadone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Morphine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Hydrocodone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Opioids Agonist Drugs Market, By Therapeutic Application, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  - Neuropathic Pain Migraine
  - Back Pain
  - Osteoarthritis Pain
  - Cancer Pain
  - Others
Cough Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Diarrhea Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Opioids Agonist Drugs Market, By Region, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Purdue Pharma
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Boehringer Ingelheim
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Janssen Pharmaceuticals, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Actavis Plc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Sun Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Mallinckrodt Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Egalet Corporation
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Endo Pharmaceuticals Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
  - Analyst Views